Le Lézard
Classified in: Health
Subjects: PDT, SVY, WOM, MAT

Flo for Partners Now Available: Unlocking Better Sex, Conception and Communication among Couples


LONDON, Oct. 19, 2023 /PRNewswire/ -- Flo, the world's leading women's health app with 57 million global monthly active users, today announced the launch of Flo for Partners, a groundbreaking feature designed to empower male partners with proactive, personalised and scientific insights into their female partner's menstrual and reproductive health. With nearly 60% of women citing their partner's limited understanding of their reproductive health as a pivotal factor in affecting their relationship dynamics, Flo for Partners serves as the ultimate translator, decoding mysteries around her sex drive, ovulation window, and pregnancy journey.

Flo for Partners is a new feature designed to empower male partners with proactive, tailored and scientific insights into their female partner's menstrual and reproductive health. Flo for Partners is available on both iOS and Android platforms in the Flo Health app. Follow the link to find out more about Flo for Partners: https://flo.health/product-tour/flo-for-partners

Flo for Partners emerged as the #1 most requested feature in 2022, reflecting a growing demand for better education and understanding surrounding women's health. With this release, Flo expands its commitment to revolutionise women's health by offering science-backed insights not only to individual users, but to couples who are seeking to improve their sex life, increase their chances of conceiving, or share their pregnancy journey together.

A recent survey, conducted by Flo, which included 1.8K UK men aged 18-50 further highlights the need for education and open communication, with findings pointing to stark knowledge gaps among men:

The lack of knowledge, misinformation and poor communication can also lead to a sexual disconnect between the partners.

For those looking to have a baby with their partner, the knowledge gaps can be a barrier to success.

"Flo for Partners is Flo's most requested feature ? and for good reason," said Cath Everett, VP of Product and Content at Flo. "Women are tired of carrying the mental load, and men are tired of being left in the dark when it comes to their partner's health journey. Whether a couple aims to spice up their love life, nail down the perfect time to conceive, or conquer pregnancy and parenthood together, Flo for Partners is the modern-day sex ed we all wish we'd had."

Key features of Flo Partner Mode include:

Flo for Partners is now available on both iOS and Android platforms. To start using Flo for Partners, female users simply need to share a unique code with their male partner, who then install Flo and input the code to gain access.

Flo remains committed to its mission of creating a better future for female health, and the protection of sensitive health information remains a top priority for Flo. Users are able to stop sharing their data at any time by tapping the "stop sharing" option within the new feature which immediately revokes partner access to all data. A full overview of privacy features can be found in our external FAQs here.

About Flo Health: Flo Health is the #1 app in the Health & Fitness category; it is the #1 OB-GYN-recommended app for period and cycle tracking based on a survey among 500 US OB-GYNs. Over 300 million people have downloaded Flo, and 57 million people use it on a monthly basis. With over 120 medical experts, Flo supports women and people who menstruate during their entire reproductive lives and provides curated cycle and ovulation tracking, personalized health insights, expert tips, and a fully closed community for users to share their questions and concerns. Flo prioritizes safety and keeps a sharp focus on being the most trusted digital source for women's health information. As part of the company's commitment to privacy, Flo Health's Anonymous Mode feature was named a finalist for Fast Company's 2023 World Changing Ideas Awards in the Rapid Response category. For more information, please visit https://flo.health.

Media Contact: 
Daria Gerasimoza
[email protected]

Flo for Partners emerged as the most requested feature in 2022, reflecting a growing demand for better education and understanding surrounding women's health. Flo for Partners offers science-backed insights to couples who are seeking to improve their sex life, increase their chances of conceiving, or share their pregnancy journey together. Follow the link to find out more about Flo for Partners: https://flo.health/product-tour/flo-for-partners

Photo - https://mma.prnewswire.com/media/2251533/PR___Image_Gallery_2.jpg
Photo - https://mma.prnewswire.com/media/2251534/PR___Image_Gallery.jpg


These press releases may also interest you

at 09:32
Scinai Immunotherapeutics Ltd.  (the "Company"), a biotechnology company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that it...

at 09:13
Methodist Le Bonheur Healthcare announced Methodist University Hospital earned top recognition by Money magazine as one of the Best U.S. Hospitals for Cardiac Care. The Memphis-based healthcare system's academic flagship landed 15th out of 75 and is...

at 09:06
Avicenna.AI, a leading medical imaging AI company, has received Medical Device Regulation (MDR) certificate for five of its algorithms from certification body BSI Medical Devices. This development means the company's product portfolio is fully...

at 09:03
Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that additional positive results from the ASPEN...

at 09:00
In March 2024, dairy cows in Texas were found to be infected with highly pathogenic avian flu, or H5N1 bird flu, in the first known case of the virus spreading to cattle. Since then, H5N1 has been found in about 200 animals?and 3 people?across 12...

at 09:00
Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2023....



News published on and distributed by: